Source: Indian Pharma Post

Axolabs: Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development

The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Roland Kreutzer's photo - Managing Director of Axolabs

Managing Director

Roland Kreutzer

CEO Approval Rating

69/100

Read more